priority review voucher

Man hands gold dollar sign to another man
Pharma

Bavarian Nordic's $160M PRV price reflects new realities

The value of PRVs appears to be on the rise as concerns mount over declining supplies following the sunset of the rare pediatric disease PRV program.
Angus Liu Jun 18, 2025 11:47am
Clock in front of the subway
Favicon Fierce Biotech

FDA 'on track' to meet all PDUFA dates, Marty Makary says

Jun 18, 2025 4:00am
rare diseases
Favicon Fierce Biotech

Stealth CEO questions FDA rejection of rare disease drug

May 29, 2025 2:27pm
signing contract

Abeona nets $155M with FDA voucher sale

May 12, 2025 9:34am
zebra

Zevra lines up $150M from sale of PRV tied to Miplyffa approval

Feb 27, 2025 9:58am
Narasimhan

Novartis complies with FDA 'flexibility' ask in Pluvicto filing

Oct 29, 2024 10:51am